United States Oral Vaccines Market Report 2018

January 2018 | 106 pages | ID: U3CE7D98C5FEN
QYResearch

Abstracts

In this report, the United States Oral Vaccines market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Oral Vaccines in these regions, from 2013 to 2025 (forecast).

United States Oral Vaccines market competition by top manufacturers/players, with Oral Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• PaxVax
• Merial
• Pfizer
• Merck
• Sanofi
• Crucell
• Quimica Suiza
• Immunitor
• Hualan Biological Engineering
• Serum Institute of India
• BB-NCIPD
• Vaxart
• Shantha Biotechnics
• Crucell (Janssen Global Services

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Rotavirus Vaccine
• Cholera Vaccine
• Polio Vaccine
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Infant
• Children
• Adults

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Oral Vaccines Market Report 2018

1 ORAL VACCINES OVERVIEW

1.1 Product Overview and Scope of Oral Vaccines
1.2 Classification of Oral Vaccines by Product Category
  1.2.1 United States Oral Vaccines Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Oral Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Rotavirus Vaccine
  1.2.4 Cholera Vaccine
  1.2.5 Polio Vaccine
  1.2.6 Others
1.3 United States Oral Vaccines Market by Application/End Users
  1.3.1 United States Oral Vaccines Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Infant
  1.3.3 Children
  1.3.4 Adults
1.4 United States Oral Vaccines Market by Region
  1.4.1 United States Oral Vaccines Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Oral Vaccines Status and Prospect (2013-2025)
  1.4.3 Southwest Oral Vaccines Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Oral Vaccines Status and Prospect (2013-2025)
  1.4.5 New England Oral Vaccines Status and Prospect (2013-2025)
  1.4.6 The South Oral Vaccines Status and Prospect (2013-2025)
  1.4.7 The Midwest Oral Vaccines Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Oral Vaccines (2013-2025)
  1.5.1 United States Oral Vaccines Sales and Growth Rate (2013-2025)
  1.5.2 United States Oral Vaccines Revenue and Growth Rate (2013-2025)

2 UNITED STATES ORAL VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Oral Vaccines Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Oral Vaccines Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Oral Vaccines Average Price by Players/Suppliers (2013-2018)
2.4 United States Oral Vaccines Market Competitive Situation and Trends
  2.4.1 United States Oral Vaccines Market Concentration Rate
  2.4.2 United States Oral Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ORAL VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Oral Vaccines Sales and Market Share by Region (2013-2018)
3.2 United States Oral Vaccines Revenue and Market Share by Region (2013-2018)
3.3 United States Oral Vaccines Price by Region (2013-2018)

4 UNITED STATES ORAL VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Oral Vaccines Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Oral Vaccines Revenue and Market Share by Type (2013-2018)
4.3 United States Oral Vaccines Price by Type (2013-2018)
4.4 United States Oral Vaccines Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ORAL VACCINES SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Oral Vaccines Sales and Market Share by Application (2013-2018)
5.2 United States Oral Vaccines Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ORAL VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oral Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 PaxVax
  6.2.2 Oral Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Merial
  6.3.2 Oral Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merial Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Oral Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Merck
  6.5.2 Oral Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Sanofi
  6.6.2 Oral Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Crucell
  6.7.2 Oral Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Crucell Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Quimica Suiza
  6.8.2 Oral Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Quimica Suiza Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Immunitor
  6.9.2 Oral Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Immunitor Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Hualan Biological Engineering
  6.10.2 Oral Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hualan Biological Engineering Oral Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Serum Institute of India
6.12 BB-NCIPD
6.13 Vaxart
6.14 Shantha Biotechnics
6.15 Crucell (Janssen Global Services

7 ORAL VACCINES MANUFACTURING COST ANALYSIS

7.1 Oral Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Vaccines Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ORAL VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Oral Vaccines Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Oral Vaccines Sales Volume Forecast by Type (2018-2025)
11.3 United States Oral Vaccines Sales Volume Forecast by Application (2018-2025)
11.4 United States Oral Vaccines Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oral Vaccines
Figure United States Oral Vaccines Market Size (K Units) by Type (2013-2025)
Figure United States Oral Vaccines Sales Volume Market Share by Type (Product Category) in 2017
Figure Rotavirus Vaccine Product Picture
Figure Cholera Vaccine Product Picture
Figure Polio Vaccine Product Picture
Figure Others Product Picture
Figure United States Oral Vaccines Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Oral Vaccines by Application in 2017
Figure Infant Examples
Table Key Downstream Customer in Infant
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure United States Oral Vaccines Market Size (Million USD) by Region (2013-2025)
Figure The West Oral Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Oral Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Oral Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Oral Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Oral Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Oral Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Oral Vaccines Sales (K Units) and Growth Rate (2013-2025)
Figure United States Oral Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Oral Vaccines Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Oral Vaccines Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Oral Vaccines Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Oral Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Oral Vaccines Sales Share by Players/Suppliers
Figure United States Oral Vaccines Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Oral Vaccines Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Oral Vaccines Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Oral Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Oral Vaccines Revenue Share by Players/Suppliers
Table United States Market Oral Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Oral Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Oral Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Oral Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Vaccines Product Category
Table United States Oral Vaccines Sales (K Units) by Region (2013-2018)
Table United States Oral Vaccines Sales Share by Region (2013-2018)
Figure United States Oral Vaccines Sales Share by Region (2013-2018)
Figure United States Oral Vaccines Sales Market Share by Region in 2017
Table United States Oral Vaccines Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Oral Vaccines Revenue Share by Region (2013-2018)
Figure United States Oral Vaccines Revenue Market Share by Region (2013-2018)
Figure United States Oral Vaccines Revenue Market Share by Region in 2017
Table United States Oral Vaccines Price (USD/Unit) by Region (2013-2018)
Table United States Oral Vaccines Sales (K Units) by Type (2013-2018)
Table United States Oral Vaccines Sales Share by Type (2013-2018)
Figure United States Oral Vaccines Sales Share by Type (2013-2018)
Figure United States Oral Vaccines Sales Market Share by Type in 2017
Table United States Oral Vaccines Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Oral Vaccines Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Oral Vaccines by Type (2013-2018)
Figure Revenue Market Share of Oral Vaccines by Type in 2017
Table United States Oral Vaccines Price (USD/Unit) by Types (2013-2018)
Figure United States Oral Vaccines Sales Growth Rate by Type (2013-2018)
Table United States Oral Vaccines Sales (K Units) by Application (2013-2018)
Table United States Oral Vaccines Sales Market Share by Application (2013-2018)
Figure United States Oral Vaccines Sales Market Share by Application (2013-2018)
Figure United States Oral Vaccines Sales Market Share by Application in 2017
Table United States Oral Vaccines Sales Growth Rate by Application (2013-2018)
Figure United States Oral Vaccines Sales Growth Rate by Application (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Oral Vaccines Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Oral Vaccines Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Oral Vaccines Revenue Market Share in United States (2013-2018)
Table PaxVax Basic Information List
Table PaxVax Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure PaxVax Oral Vaccines Sales Growth Rate (2013-2018)
Figure PaxVax Oral Vaccines Sales Market Share in United States (2013-2018)
Figure PaxVax Oral Vaccines Revenue Market Share in United States (2013-2018)
Table Merial Basic Information List
Table Merial Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merial Oral Vaccines Sales Growth Rate (2013-2018)
Figure Merial Oral Vaccines Sales Market Share in United States (2013-2018)
Figure Merial Oral Vaccines Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Oral Vaccines Sales Growth Rate (2013-2018)
Figure Pfizer Oral Vaccines Sales Market Share in United States (2013-2018)
Figure Pfizer Oral Vaccines Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Oral Vaccines Sales Growth Rate (2013-2018)
Figure Merck Oral Vaccines Sales Market Share in United States (2013-2018)
Figure Merck Oral Vaccines Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Oral Vaccines Sales Growth Rate (2013-2018)
Figure Sanofi Oral Vaccines Sales Market Share in United States (2013-2018)
Figure Sanofi Oral Vaccines Revenue Market Share in United States (2013-2018)
Table Crucell Basic Information List
Table Crucell Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Crucell Oral Vaccines Sales Growth Rate (2013-2018)
Figure Crucell Oral Vaccines Sales Market Share in United States (2013-2018)
Figure Crucell Oral Vaccines Revenue Market Share in United States (2013-2018)
Table Quimica Suiza Basic Information List
Table Quimica Suiza Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Quimica Suiza Oral Vaccines Sales Growth Rate (2013-2018)
Figure Quimica Suiza Oral Vaccines Sales Market Share in United States (2013-2018)
Figure Quimica Suiza Oral Vaccines Revenue Market Share in United States (2013-2018)
Table Immunitor Basic Information List
Table Immunitor Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Immunitor Oral Vaccines Sales Growth Rate (2013-2018)
Figure Immunitor Oral Vaccines Sales Market Share in United States (2013-2018)
Figure Immunitor Oral Vaccines Revenue Market Share in United States (2013-2018)
Table Hualan Biological Engineering Basic Information List
Table Hualan Biological Engineering Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hualan Biological Engineering Oral Vaccines Sales Growth Rate (2013-2018)
Figure Hualan Biological Engineering Oral Vaccines Sales Market Share in United States (2013-2018)
Figure Hualan Biological Engineering Oral Vaccines Revenue Market Share in United States (2013-2018)
Table Serum Institute of India Basic Information List
Table BB-NCIPD Basic Information List
Table Vaxart Basic Information List
Table Shantha Biotechnics Basic Information List
Table Crucell (Janssen Global Services Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Vaccines
Figure Manufacturing Process Analysis of Oral Vaccines
Figure Oral Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Oral Vaccines Major Players/Suppliers in 2017
Table Major Buyers of Oral Vaccines
Table Distributors/Traders List
Figure United States Oral Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Oral Vaccines Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Oral Vaccines Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Oral Vaccines Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Oral Vaccines Sales Volume (K Units) Forecast by Type in 2025
Table United States Oral Vaccines Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Oral Vaccines Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Oral Vaccines Sales Volume (K Units) Forecast by Application in 2025
Table United States Oral Vaccines Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Oral Vaccines Sales Volume Share Forecast by Region (2018-2025)
Figure United States Oral Vaccines Sales Volume Share Forecast by Region (2018-2025)
Figure United States Oral Vaccines Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources